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Abstract
Background: The Structural Maintenance of Chromosome 3 protein (SMC3) plays an essential
role during the sister chromatid separation, is involved in DNA repair and recombination and
participates in microtubule-mediated intracellular transport. SMC3 is frequently elevated in human
colon carcinoma and overexpression of the protein transforms murine NIH3T3 fibroblasts. In
order to gain insight into the mechanism of SMC3-mediated tumorigenesis a gene expression
profiling was performed on human 293 cells line stably overexpressing SMC3.
Results: Biotinylated complementary RNA (cRNA) was used for hybridization of a
cDNAmicroarray chip harboring 18,861 65-mer oligos derived from the published dEST sequences.
After filtering, the hybridization data were normalized and statistically analyzed. Sixty-five genes for
which a putative function could be assigned displayed at least two-fold change in their expression
level. Eighteen of the affected genes is either a transcriptional factor or is involved in DNA and
chromatin related mechanisms whereas most of those involved in signal transduction are members
or modulators of the ras-rho/GTPase and cAMP signaling pathways. In particular the expression of
RhoB and CRE-BPa, two mediators of cellular transformation, was significantly enhanced. This
association was confirmed by analyzing the RhoB and CRE-BPa transcript levels in cells transiently
transfected with an SMC3 expression vector. Consistent with the idea that the activation of rasrho/GTPase and cAMP pathways is relevant in the context of the cellular changes following SMC3
overexpression, gene transactivation through the related serum (SRE) and cAMP (CRE) cis-acting
response elements was significantly increased.
Conclusion: We have documented a selective effect of the ectopic expression of SMC3 on a set
of genes and transcriptional signaling pathways that are relevant for tumorigenesis. The results lead
to postulate that RhoB and CRE-BPa two known oncogenic mediators whose expression is
significantly increased following SMC3 overexpression play a significant role in mediating SMC3
tumorigenesis.

Introduction
The Structural Maintenance of Chromosome 3 protein
(SMC3) is a key component of the nuclear multimeric

protein complex named cohesin. This complex, which
also includes SMC1, scc1 and scc3, forms joints between
the replicating DNA strands and holds together the sister
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chromatids throughout G2 phase while opposing the
splitting force exerted by the spindle microtubules [1]. In
addition to its essential role in mitotic and meiotic chromosome segregation, SMC3 plays an important role in
DNA recombination [2], is a component of the DNA
damage repair mechanism [3] and is involved in the
microtubule-based intracellular transport [4]. SMC3
expression is elevated in a large fraction of human colon
carcinoma and in the intestinal tumors of mice genetically
prone to develop polyps [5]. SMC3 expression level is
controlled in intestinal epithelial cells through the APC/βcatenin/TCF4 transactivation pathway a signaling system
that is almost invariably altered in colon carcinomas [6].
Furthermore NIH3T3 fibroblasts overexpressing SMC3
lose cell-cell contact inhibition, display anchorage-independent growth and form foci of transformation [5].
These findings support the idea that up-regulation of
SMC3 expression is either permissive or sufficient to trigger cell transformation. The mechanism of SMC3-mediated cell transformation has however remained
speculative.
In order to identify genes whose expression is affected by
SMC3 overexpression, high-density oligonucleotide
microarray chip harboring 18,861 human gene-specific
oligonucleotides were hybridized with cRNA derived
from 293 cells with different expression level of SMC3.
The 293 cells are human embryonic kidney cells that have
become immortalized following transformation by adenovirus type 5 [7] and display latent tumorigenicity [8].
This represent a well characterized model for human tumorigenesis that has been frequently utilized for in vitro and
in vivo assessment of the oncogenic or tumor suppressor
potential of a number of genes [9-13]. Statistical analysis
of the microarray data has revealed that many of the genes
affected by SMC3 overexpression in 293 cells are members or modulators of the ras-rho/GTPase family of proteins and of the cAMP signaling pathway. The analysis of
the activity of a panel of reporter vectors monitoring different transactivation pathways further corroborates the
idea that ras-rho/GTPase and cAMP response element
binding proteins play a predominant role in orchestrating
the cell changes subsequent to SMC3 overexpression. In
particular RhoB and CRE-BPa, two major modulators of
cellular transformation and response to genotoxic stress
and whose level is significantly increased following SMC3
overexpression, may act as important mediators of SMC3
activity at cellular level.

Results and Discussion
A microarray analysis of the genome-wide effect of SMC3
overexpression identifies candidate genes mediating SMC3
tumorigenicity
The identification of genes that are affected by SMC3 upregulation may provide important clues regarding the
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biology of this cohesin protein and shed light on the
mechanism at the basis of the SMC3-induced tumorigenesis. Toward this end the changes in gene expression
caused by sustained SMC3 overexpression were analyzed
in fetal kidney 293 cells using a large microarray of
human gene-specific oligonucleotides. Stable overexpression of SMC3 in these cells was assessed by semi-quantitative RT-PCR and the result confirmed in cells at a later
division stage by Western immunoblotting (fig. 1). On
the average we detected ~3-fold elevation of the SMC3
mRNA and protein levels. These values compare well with
the 2-folds elevation of SMC3 transcript level measured in
the microarray analysis (Table I). Of relevance is the fact
that these changes in expression level are similar to those
previously detected in a series of human colon carcinomas
and in the intestinal polyps of APC+/min mice or in
NIH3T3 cells genetically engineered to ectopically express
SMC3 [5]. A comparable increase in SMC3 expression has
also been detected in liver metastatic cancer cells [14], in
marrow stem cells exiting quiescence [15], in vascular
endothelial cells following angiogenic stimulus [16], and
in human T-cells infected with Varicella-Zoster [17] suggesting that maximal achievable SMC3 expression level is
similar in different cell and tissues contexts. Interestingly
these changes in transcriptional activity are not accompanied by significant changes in the expression of the other
components of the cohesin complex consistent with the
idea that SMC3 level is regulated independently from that
of the other partner proteins.
To ensure the accurate identification of genes whose regulation is altered in response to SMC3 overexpression, the
array data were normalized and filtered to exclude gene
displaying high inter-array variability [18] and then statistically analyzed with SAM [19] (fig. 2). The algorithm
uncovered 114 genes that either increase (n = 70) or
decreased (n = 44) their expression level by at least twofolds. Differentially expressed genes with an entry in the
Unigene database were classified according to their putative main function and listed in Table I. About one-fifth of
the affected genes encode secreted or cell surface proteins
such as components of the extracellular matrix or cell surface receptors and growth factors. This group of genes
includes Glypican 3 a heparan sulfate proteoglycan that is
a cell surface co-receptor for heparin-binding growth factors and is elevated in several forms of cancer [20]. About
two-third of the differentially expressed genes is engaged
in signal transduction and gene transactivation. In this
group there are genes involved in cAMP signal transduction such the adenylate cyclase 2, CREM and CRE-BPa
[21,22]. Further examination of the list of the affected
genes reveals a rather specific effect of SMC3 on the
expression of genes that are effectors (RhoB and RAB40B)
or modulators (ARHGEF4, RGS14, RIN3, PDE6B, ADPrybosyltransferase) of the ras-rho/GTPase signaling

Page 2 of 12
(page number not for citation purposes)

Molecular Cancer 2005, 4:34

Figure 1human
Identification
pressing
andSMC3
characterization of 293 cells stably overexIdentification and characterization of 293 cells stably
overexpressing human SMC3. a): 293 cells were transfected with SMC3-pcDNA3.1 expression vector or the
empty vector alone. Cell clones with stably integrated vector
were selected in medium containing 500 µg/ml of G418 for
three weeks. The expression of SMC3 and of the housekeeping gene G3DPH in drug-resistant clones was evaluated by
semi-quantitative RT-PCR. b): SMC3 expression analysis was
repeated on cells at later passages to confirm that clones stably overexpressing SMC3 were used. This time SMC3
expression was examined by Western immunoblotting. For
this purpose cells were solubilized in lysis buffer and analyzed
by 8% SDS-PAGE. After transfer of the proteins to nitrocellulose, SMC3 was immunodetected using a goat polyclonal
antibody followed by ECL detection of the immunocomplex.
The expression of α-tubulin was used to assess the intersample variability using nitrocellulose filters stripped of the
SMC3 immunocomplexes.

pathway [23-25]. Rho is a family of small GTPases that is
not mutated in cancer and therefore their involvement in
tumorigenesis is dependent upon the activation status
and the expression level. The up-regulation of RhoB
expression may be of particular relevance in the context of
SMC3-mediated tumorigenesis. RhoB is an early response
gene that is transcriptionally activated following DNA
damage [26] through a mechanism requiring ATF2-mediated gene transactivation [27]. ATF2 is a member of the
CRE-binding protein gene family whose transcriptional
activity is in turn directly regulated by ATM in response to
genotoxic stress [28]. Interestingly an ATM-dependent
pathway is also responsible for the phosphorylation of
SMC3 in response to irradiation [3] raising the possibility
that RhoB and SMC3 are members of the same DNA integrity surveillance pathway. Other findings suggest that
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SMC3 and RhoB expression may be linked. The expression of these genes is increased following activation of the
Wnt/β-catenin/TCF4 transactivation [6,29]. On the other
hand SMC3 and RhoB expression is negatively affected by
Ras [30,31]. RhoB has both a positive and negative role in
cell growth and it has been postulated it operates in a contextual manner. For example RhoB is essentially required
for Ras-mediated transformation but at the same time it is
necessary for the apoptotic response of transformed cells
to DNA-damaging agents [25-27], suppresses tumorigenesis and restrains the transformed characteristics of neoplastic cells [32]. SMC3-transformed cells however do not
display sign of apoptosis as revealed by Annexin V binding or propidinium iodine nuclear staining (data not
shown). Furthermore, as revealed by the microarray analysis, the expression of apoptotic agents and mediators was
not affected by SMC3 upregulation (Table I). Given that
RhoB and SMC3 may exert opposite effect on cell transformation, we postulate that SMC3 oncogenic activity prevails by overcoming the pro-apoptotic action of RhoB.
SMC3 acts as an oncogene in human cells and activates
the expression of a set of early-response genes
In order to assesses whether changes in the gene expression observed in cell stably overexpressing SMC3 are part
of an early response to SMC3 elevation and may thus
mediate the tumorigenic potential of this cohesin protein,
293 cells were transiently transfected with SMC3pcDNA3.1 or alternatively with the empty expression vector (fig. 3a). Ectopic expression of SMC3 in 293 cells
enhanced cell proliferation (fig. 3b) and promoted cell
aggregation, rounding and piling as observed when the
cells were cultured in serum-deficient medium (fig. 3c,d).
As anchorage-independent growth is considered to be in
vitro test for tumorigenesis, we examined the growth of
SMC3-transfected 293 cells in a semi-soft agarose
medium. Scoring of the number and the size of the colonies formed revealed that SMC3 acts as an inducer of cell
transformation. Not only the percent of colonies formed
was increased (~95% compared to ~50% originating from
pcDNA3.1-transfected cells) but the colonies formed after
three weeks where significantly larger (12 ± 3 colonies of
diameter of >100 µm/9 mm2 vs. none generated by
pcDNA3.1-transfected cells) (fig. 3e,f). These results demonstrate that SMC3 has the ability to enhance the
tumorigenic potential of immortalized human cells.
SMC3 does not require the ectopic co-expression of other
oncogenes to achieve its tumorigenic function.

Cells transiently transfected with SMC3-pcDNA3.1 displayed at 3-folds increase in SMC3 transcript level. This
was matched by a 5-fold elevation of RhoB transcript level
(fig 4a). The effect of SMC3 was confirmed when RhoB
protein level was assessed by immunoblotting (fig. 4b).
Because SMC3 has the capability to transform NIH3T3
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Table 1: Significantly regulated genes in SMC3 overexpressing 293 cells. Human expressed sequence tags and genes with no known
function are not included. Complete results of the array have been submitted to the EBI microarray database.

Genes

SAM Score

Fold changes

Bamacan/SMC3

2.06

2.04

2.55
2.05
1.89
-1.99

2.49
2.13
2.03
-3.76

3.15
1.85
-2.00

2.40
2.02
-2.00

2.58
2.00
2.25
1.94
2.53
1.81

2.65
2.28
2.20
2.16
2.05
2.00

1.95
2.04
1.83
1.88
1.81
2.23
-2.17
-2.20
-2.22
-1.91
-2.20

2.68
2.54
2.23
2.19
2.15
2.04
-2.13
-2.16
-2.48
-3.03
-4.18

2.36
2.17
2.09
2.16
1.86
1.81
2.31
2.16
1.91
2.02
-1.92
-1.92
-1.92

2.85
2.57
2.46
2.38
2.19
2.18
2.08
2.06
2.15
2.09
-2.16
-2.86
-3.03

2.14
2.20

3.96
3.28

Extracellular Matrix
GPC3, glypican 3
lectin, mannose-binding, 1 like
HAS2, hyaluronan synthase 2
LAMB3, lamin, beta 3
Transporter and ion channels
ATP6V1B1, ATPase, H+ transporting V1 subunit B, kidney isoform
KCTD12, potassium channel tetramerisation domain 12
SLC7A10, solute carrier family 7 member 10, neutral amino acid transporter
Metabolism
MIG12, MID1 interacting G12-like protein
CKB, creatine kinase, B chain
ECHDC3, enoyl Coenzyme A hydratase domain containing 3
ALDH1A3, aldehyde dehydrogenase 1 family, member A3
MOXD1, monooxygenase, DBH-like 1
TXNRD3, thioredoxin reductase 3
Growth factors and receptors
LTBP2, latent transforming growth factor beta binding protein 2
GABRE, gamma-aminobutyric acid A receptor, epsilon
DLL1, delta-like 1, notch ligand
GDF9, growth differentiation factor 9
IGFBP7, insulin-like growth factor binding protein 7
GNRH1, gonadotropin-releasing hormone 1
IRAK1, interleukin-1 receptor associated kinase 1
EGFL3, EGF-like-domain, multiple 3
IL22RA1, interleukin 22 receptor, alpha 1
OR4D1, olfactory receptor, family 4, subfamily D, member 1
GRB7, growth factor receptor-bound protein 7
Signal Transduction
ARHGEF4, Rho guanine nucleotide exchange factor 4
RGS14, regulator of G-protein signaling 14
RPS6KA5, ribosomal protein S6 kinase, polypeptide 5
PAK6, p21-activated kinase 6
RIN3, Ras and Rab interactor 3
RHOB, ras homolog gene family, member B
SCFD1, sec1 family domain containing 1
LRRK1, leucine-rich repeat kinase 1
RAB40B, GTP-binding protein 40B
PDE6B, phosphodiesterase 6B, cGMP-specific
MCF2L, MCF.2 cell line derived transforming sequence
S100A8, S 100 calcium binding protein A8, calgranulin A
ADCY2, adenylate cyclase 2
Transcriptional factors
MEOX2, mesenchyme homeobox 2, growth arrest specific homeobox
IRF4, interferon regulatory factor 4
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Table 1: Significantly regulated genes in SMC3 overexpressing 293 cells. Human expressed sequence tags and genes with no known
function are not included. Complete results of the array have been submitted to the EBI microarray database. (Continued)

KHDRBS3, KH domain, RNA binding, signal transduction associated 3
PPARA, peroxisome proliferative activated receptor, alpha
CRE-BPa, cAMP responsive element binding protein, ATF2-like
NEK9, never-in-mitosis-gene a-related kinase 9
CREM, cAMP responsive element modulator
NCOA6, nuclear receptor coactivator 6
TXB21, T-box 21
POU3F1, POU domain, class 3, octamer-binding TF6
NKX6-1, NK6 transcriptional factor related, locus 1, homeobox 6A
CTNNA1, catenin alpha 1
BCL6B, B-cell CLL/lymphoma 6, member B zinc finger protein
ZNF236, zinc finger protein 236

2.24
2.22
1.94
1.83
-1.87
-1.88
-1.88
-2.21
-1.90
-1.90
-2.72
-1.90

2.62
2.50
2.37
2.33
-2.11
-2.32
-2.42
-2.44
-2.53
-2.57
-2.79
-3.11

2.76
1.88
2.11
-2.25

2.81
2.07
2.00
-2.64

2.77
2.53
2.09
2.15
-2.17
-1.94
-2.02
-1.90
-2.01
-2.18

5.10
2.56
2.46
2.09
-2.09
-2.14
-2.27
-2.38
-2.50
-3.98

DNA repair, gene transcription
MHL3, mutL homolog 3
DNMT2, DNA cytosine-5-methyltransferase 2
ADPRTL2, ADP-ribosyltransferase 2
SNRPN, small nuclear ribonuclear polypeptide N
Various
MYOM2, myomesin 2
NOPE, neighbor of Punc E11
C5, complement component 5
COCH, coagulation factor C homolog, cochlin
VMD2L1, vitelliform macular dystrophy 2-like 1
GRN, granulin
HPN, hepsin serine protease
LPHN1, latrophilin 1
PRND, prion protein 2
HYPM, huntingtin interacting protein M

cells [5] we examined whether the ectopic expression of
SMC3 enhances RhoB expression in the murine fibroblasts. The Western immunoblotting results confirmed this
hypothesis (fig. 4b). The finding corroborates the idea
that a causal link exist between SMC3 and RhoB expression that is not restricted to a specific cell context. The
mechanism whereby SMC3 elevation leads to RhoB
upregulation can be only presently speculated. It has been
reported that interference with the cohesin complex turnover, such as it may occur when SMC3 level is elevated,
causes derangement of the cell cycle progression and
increases the number of chromosomal segregation errors
leading to DNA breakage and aneuploidy [33]. As discussed previously, the ensuing activation of the ATM pathway may lead to RhoB transactivation via a CREBdependent mechanism [27,28]. The evidence that p53and CRE-mediated gene transactivation are enhanced in
cells constitutively overexpressing SMC3 (fig. 5), is consistent with an activation of the ATM-dependent pathway
[34] and corroborates this scenario. The upregulation of
MLH3 and DNMT2 (see Table I) – two genes involved in

DNA base mismatch repair, further supports this
hypothesis. DNA damage would normally result in cell
cycle arrest. Cells constitutively overexpressing SMC3
however display enhanced growth rate suggesting that
they can escape the surveillance of the cell cycle gatekeepers. Recently SMC3 has been identified as a component of
a complex including SMC1 and BRCA1, that operates as
an effector in the ATM-dependent S-phase checkpoint
[3,35]. It is possible that when present in excess SMC3 acts
in dominant-negative fashion with respect to the activity
of the SMC1/SMC3/BRCA1 complex affecting the efficacy
of the ATM-dependent S-phase checkpoint.
Further analysis of SMC3-transfected 293 cells and the
parent cells provided evidence that in addition to RhoB
also CRE-BPa, RGS14 and ARHGEF4 are part of the set of
genes activated following transient elevation of SMC3.
RGS14 is a target of the p53 tumor suppressor and its
overexpression inhibits both Gi- and Gq-coupled growth
factor receptor mediated activation of the mitogen-activated protein kinase signaling pathway in mammalian
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4

3

2

Observed

1

0
-3

-2

-1

0

1

2

3

-1

-2

-3

-4
Expected

Two-class
Figure 2 analysis of the microarray data set
Two-class analysis of the microarray data set. The six 293 cells arrays (three from the control clones, and three from
the SMC3-overexpressing clones) were subjected to SAM two-class unpaired analysis where the software created a field of
observed versus expected gene regulation values from the array data. A delta parameter (0.409) was chosen to limit the field
and provide the optimal output of significantly to falsely significantly regulated genes (16 in our analysis). The threshold was set
at 1.00 corresponding to a twofold difference in regulation from the control cells when data are entered as log2 values. Dashed
lines: delta parameter which defines the significance field; dots above the upper line: probable significantly up-regulated genes;
dots below the lower line: probable significantly down-regulated genes.

cells [36]. Because p53 transactivation pathway is activated following SMC3 overexpression (see below) we postulate that RGS14 may be involved in counteracting the
SMC3 mitogenic activity. ARHGEF4 (also known as Asef)
is a Rac-specific guanine nucleotide exchange factor that is
activated following binding to APC [37,38]. APCARHGEF4 complex plays an important role in the regulation of the actin cytoskeleton, cell morphology and migration and affects E-cadherin-mediated cell-cell adhesion.
Agents such as ARHGEF4 may thus act as mediators of the
effect of SMC3 overexpression on cell growth and
morphogenesis.

SMC3 overexpression specifically activates the SRE and
CRE transactivation pathways
To further examine the cellular response to SMC3 overexpression, the activation level of a number of
transactivation pathways was investigated. We reason that
selective changes in transcriptional activity could further
sort out the key players mediating the SMC3 biological
activity. For this purpose 293 cells were transfected with
SMC3 expression vector or pcDNA3.1 vector alone
(control group) together with a series of luciferase reporters whose expression is driven by target-specific cis-acting
elements present in multiple copies in the vector promoter. The serum responsive element (SRE) is a known
target of RhoB as well as of other ras-rho/GTPase [25].
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Figureof3SMC3 overexpression on 293 cells colony growth
Effect
Effect of SMC3 overexpression on 293 cells colony growth. a): 293 cells at 70% confluence were transfected with 1 µg/
ml of pcDNA3.1 (control) or SMC3-pcDNA3.1 expression vectors and cell RNA collected after 48 hrs in 1 ml TriReagent.
SMC3, and G3PDH transcript levels were assayed by semiquantitative RT-PCR and the products analyzed by agarose electrophoresis. The result of a control and two independent samples of cells transfected with SMC3-pcDNA3.1 are shown. b)
Growth rate of cells overexpressing SMC3. Cells were seeded in 96-well plates (2,500 cells/well in a final volume of 150 µl) in
DMEM medium supplemented with 1.5% FCS. Cell proliferation was assessed by using a CellTiter 96 colorimetric assay. Each
point represent the mean ± SD of four independent determinations. c,d) Transfected cells were seeded in 35 mm plates and
grown for 10 days in DMEM supplemented with 1.5% FCS. To detect foci of transformation, cells were fixed in 70% ethanol
followed by staining with 0.1% methylene-blue. e,f) Colony formation in semisoft agarose. Twenty-four h after transfection,
cells were trypsinized and resuspended in 0.2% agarose in DMEM containing 10% fetal bovine serum and plated on top of solidified agarose (0.4%) dissolved in the same medium in 35 mm dishes. After 3 weeks of culture cell colonies were examined
under a light microscope.

Consistent with the idea that elevation of RhoB is functionally significant a 2.8-fold elevation of SRE-transactivation activity was detected in SMC3-overexpressing cells
(fig. 5). On the contrary AP1-dependent gene transactivation which is mediated by c-jun, c-fos and ATF2 homo or
heterodimers, was significantly suppressed. Given that
RhoB, but not other ras-rho/GTPase, suppresses AP1mediated gene transactivation [30] this result support the
idea that following SMC3 elevation, RhoB plays a central
role in mediating gene transactivation. Consistent with a
major role of the CREB in the SMC3 mediated cell events,
the response of the CRE-dependent reporter was greatly
increased (2.6-fold) in cells stably overexpressing SMC3.
This cAMP responsive element is a bona-fide target for the
CRE-BPa transcriptional factor whose expression is significantly increased following SMC3 elevation (Table I, fig.
4a). CRE-BPa is a member of the ATF2 cAMP-binding proteins family that is activated by a variety of kinases including protein kinase A, JNK/SAPK, p38-MAPK, AKT, and
calcium-calmodulin-dependent kinases and is involved in

tumorigenesis of endocrine tissues and different forms of
leukemia [21]. To the activation of the CREB
transactivation pathway may also contribute the downregulation of CREM, a gene encoding several spliced
products some of which are CRE-transactivation repressors [22]. The glucocorticoid, TGFβ-activin and of NF-kB
transactivation pathways are potential target of RhoB or
CRE-BPa, and their activity was also tested [26,39,40].
NFkB-mediated transactivation which has been reported
to be downregulated by RhoB in NIH3T3 cells [26] was
not significantly affected in our experiments suggesting
that this regulatory mechanism is either cell context-specific or that SMC3 elicits other changes that counterbalance the RhoB-dependent NF-kB loss of activity. Likewise
gene transactivation from the GRE and TARE cis-acting
elements was not affected. Taken together the results are
consistent with the idea that following SMC3 elevation,
SRE- and CRE- mediated gene transactivation is specifically engaged.
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Figureof4SMC3 on the expression of a set of early-response genes
Effect
Effect of SMC3 on the expression of a set of early-response genes. a) Cells were transfected with 1 µg/ml of
pcDNA3.1 (control) or SMC3-pcDNA3.1 and RNA collected after 48 hrs in 1 ml TriReagent. Gene transcripts were amplified
by RT-PCR and the products analyzed by agarose electrophoresis. b) Analysis of RhoB level in NIH-3T3 and 293 cells overexpressing SMC3. Cells were transfected as in a) and 48 h later solubilized in lysis buffer. Twenty and 50 µg respectively of NIH3T3 and 293 cell lysate proteins were analyzed by 12.5% SDS-PAGE. After transfer to nitrocellulose, RhoB was immunodetected using a rabbit polyclonal antibody followed by ECL detection of the immunocomplex. Nitrocellulose-bound proteins
were stained with Ponceau-red to evidence the amount of proteins loaded.

Conclusion

Methods

The results presented provide a molecular signature of the
changes that occurs in epithelial cells following SMC3
overexpression. In particular we document a selective
effect of the ectopic expression of SMC3 on a set of earlyresponse genes such as RhoB and CRE-BPa and on the
related transcriptional pathways SRE and CRE that play
key roles in tumorigenesis. SMC3 acts as an oncogene in
human cells and we show that RhoB and CRE-BPa are part
of a set of genes activated following transient SMC3 transfection. These findings provide important initial information on the chain of events occurring following SMC3
overexpression that will allow in future studies to focus on
the underlying mechanism of the association between
SMC3 deregulation and specific oncogenic pathways.

Establishment of cell lines stably overexpressing SMC3
293 cells were grown to 70% confluence in 10 cm plates
and transfected with 3 µg of pcDNA3.1 expression vector
harboring the entire human SMC3 coding sequence
(SMC3-pcDNA3.1) [5] and using Lipofectamine as transfecting agent. To generate a control cell line a second
batch of cells was transfected instead with the empty
pcDNA3.1 vector. After 48 h stably transfected cells were
selected in medium containing 500 µg/ml of G418.
Clones of the surviving cells were expanded and SMC3
expression examined by semi-quantitative RT-PCR. For
this purpose, 1 µg of cell RNA was reverse transcribed with
Sensiscript (Qiagen) reverse transcriptase priming with
oligo-dT. An aliquot of the RT reaction product was
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Figure 5
Transcriptional
activity in control and SMC3 overexpressing cells
Transcriptional activity in control and SMC3 overexpressing cells. Cells were seeded in 12 well plates and used at
70% confluence. Treatment groups, each as triplicate samples, were transfected with 0.1 µg/ml of the indicated reporter vector
together with 0.01 µg/ml of PH-RL transfection control vector using 5 µl/ml Lipofectamine. The reporter vectors harbor multiple repeats of the consensus sequence for different transcriptional binding sites which drive the expression of a firefly luciferase. Transactivation activity was calculated based on the firefly luciferase level correcting for the transfection efficiency using
the renilla luciferase level in a dual luciferase assay. Data shown are the mean ± SD from three independent determinations. * p
< 0.01 SMC3-overexpressing vs. control.

amplified using ExTaq (Takara) DNA polymerase and
SMC3-specific primers of sequence: 5'-GAGTAGAAGAACTGGACAGA-3' and 5'-GATTGTACCTCAGTTTGCTG-3'. To ensure that the amplification reaction had
not reached saturation, DNA production was monitored
after 25 and 30 cycles by analysis on 1% agarose and by
staining with ethidium bromide. Gels were photographed, the picture scanned and the band intensity quantified by densitometry with an image scanner. SMC3
protein expression was assessed by Western immunoblotting. Briefly, cell lysates in 150 mM NaCl 1% Nonidet P40
0.5% Na-deoxycholate 50 mM Tris-HCl pH 7.4 were electrophoresed on 8% SDS-PAGE slab gel and the separated
proteins transferred onto a nitrocellulose filter. Immunoblotting was performed with goat anti-human SMC3
(1:1,000) antibody (Santa Cruz Biotech) at 25°C for 1 h,
followed by incubation in anti-goat IgG horseradish peroxidase conjugated (1:10,000) secondary antibody.

Immunocomplexes were identified using an enhanced
chemiluminescence (ECL) kit (Pierce) followed by autoradiograph. Three SMC3 overexpressing clones and three
control clones were selected for the gene expression
profiling.
Microarrays and data analysis
For the target preparation, 5 µg of human untransfected
and transfected 293 cell line total RNA were reverse transcribed with SuperscriptT-II/RNaseH- priming with T7(dT)24 oligonucleotides and the second-strand cDNA
synthesized using E. coli DNA polymerase I [18]. Biotinylated cRNA was generated using T7 RNA polymerase
and Biotin 11-UTP. Ten µg of purified unfragmented target cRNA was used for hybridization of each KCC/TJU
human 18.5 K Expression Bioarray (Compugen Human
Oligo Set 1.0) chip containing 18,861 oligos (65-mer)
corresponding to 17,260 unique clusters and 18 bacterial
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control probes. The microarrays were hybridized, washed,
and processed using a direct detection method of the
biotin-containing transcripts by a Streptavidin-Alexa647
conjugate. Processed slides were scanned using a Perkin
Elmer ScanArray XL5K scanner and the spot intensity
quantitated using the ScanArray Scanning and QuantArray programs (PerkinElmer) [18]. The chips analyzed presented consistent staining over the entire microarray and
had appropriate data distribution. Spots with raw intensity value comprised within one SD from the average
background value were excluded from the analysis. The
remaining values – about 90% of the whole arrayed genes,
were normalized by dividing each spot's intensity (after
background subtraction) by the median signal intensity of
all test probes. Genes that displayed inter-array variability
exceeding one SD unit were furthermore excluded from
the final statistical analysis. The data and protocols have
been submitted to the EBI ArrayExpress database (samples
171479SUB800 through 171484SUB800).
Statistical analysis of the microarray data
We input the log2 of the gene expression measurements
from three sets of microarray experiments each including
a control and an SMC3 overexpressing cell sample.
Through a series of permutation the program computes a
statistic score di for each gene i measuring the strength of
the relationship between gene expression and the
response variable and creates a profile of observed versus
expected values. The values which lie outside a userdefined region that can be adjusted to achieve an optimum of positive vs. false positive values, are considered
significantly related to the response and thus regarded as
significantly regulated genes (see fig. 2). Since each experiment consisted of the data from two independent chips
hybridized with the control and the SMC3-overexpressing
cells cDNA, an unpaired two-class analysis was carried out
to discover significant changes in gene regulation compared to the control cell line.
Gene transactivation activity assay
Reporter vectors harboring multiple copies of the consensus sequences for the AP1, cAMP (CRE), serum (SRE),
p53, TGFβ (TARE), NF-kB and glucocorticoid (GRE)
response elements, were obtained from Stratagene or
Clontech. Cells cultures at 70% confluence in 12 wells
plates were used in all the experiments. The transfection
mix contained 10 ng/ml of phRL-SV40 plasmid to monitor the transfection efficiency, 100 ng/ml of the designed
plasmid, and 1 µg/ml of SMC3-pcDNA3.1 expression
vector. Plasmids were mixed in medium 199 followed by
the addition of 10 mg/mg DNA of Tfx-50 (Promega)
transfection agent according to the manufacturer directions and finally added to the cultures. After 1 h incubation at 37°C in humidified incubator the cells were
supplemented with 2 ml of growth medium and the luci-
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ferase activity assayed 24 h later using a Promega dualluciferase kit. All experiments were carried out with triplicate samples. The statistical difference between groups of
data was analyzed by Student's t-test.
SMC3 transient transfection and gene transcript level
analysis
Cells (either 293 or NIH3T3) at 70% confluence were
transiently transfected with 1 µg/ml of SMC3-pcDNA3.1
expression vector using Lipofectamine as transfection
agent. Control cells were transfected instead with 1 µg/ml
of pcDNA3.1 empty vector. After 48 h, the cells were
washed in PBS and the total RNA extracted with TriReagent. Gene transcripts were amplified by RT-PCR and the
products quantified by gel electrophoresis. The primers
used had the following sequence: RhoB: 5'-CCTGCTGATCGTGTTCAGTAA-3' and 5'-TCATAGCACCTTGCAGCAGTT-3'; CRE-BPa: 5'-ATGATTTATGAGGAATCCAAGAT
G-3'
and
5'-TTAAAGAATCGGATTCAGGTCTGT-3';
RGS14: 5'-CTGGTGGGCAATGAACAGAAGGCC-3' and
5'-GGGCTGAGTCGGTGGTGGAGTTCA-3'; ARHGEF4: 5'AGCCTCAAGCCAAAAGCCAGCAGC-3'
and
5'CTCACTTGCTGGCAGAGGAAGGCCA-3'; G3PDH: 5'TGAAGGTCGGAGTCAACGGATTTGGT-3' and 5'-CATGTGGGCCATGAGGTCCACCAC-3'. RhoB protein level in
cells was examined by Western immunoblotting as
described previously using a rabbit polyclonal antibody
(1:1,000) from Bethyl.
Cell proliferation assay
Cell proliferation was examined using a CellTiter 96
(Promega) assay kit according to the manufacturer's
instructions. Cells growing in log phase were trypsinized
and seeded in 96-well plates (2,500 cells/well in a final
volume of 150 µl) in replicates of 4 and incubated at 37°C
in 5% CO2 and 95% air in DMEM medium containing
1.5% FCS. At 24 h, 72 h or 96 h, 20 µl of the kit dye solution was added to each well and the plates incubated at
37°C for an additional 1 h. The absorbance of the formazan product generated was measured at 490 nm using a
96-well Dynatech MR600 plate reader.
Cell overgrown assay
In order to examine the ability of cells to form foci of
transformation, cells were seeded at 30% confluence in 35
mm plates and cultured in DMEM supplemented with
1.5% medium. After 7 days the medium was removed, the
cell washed with PBS, and fixed with 70% ethanol on ice.
Foci of cell aggregation were evidenced by staining with
0.1% methylene-blue dissolved in water followed by 3
washing in water to decrease background staining.
Anchorage-independent cell growth in soft agar
Anchorage-independent colony formation of cells was
assayed as described [5]. Briefly, cells growing in log-
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phase were trypsinized and resuspended at 37°C in 0.2%
agarose in DMEM containing 10% fetal bovine serum and
plated on top of solidified agarose (0.4%) dissolved in the
same medium in 35 mm dishes. After 3 weeks of culture
at 37°C in CO2 humidified incubator, the number of cell
aggregates over that of single cells and the number of colonies of diameter >100 µm found in randomly selected
areas of 9 mm2, was recorded.
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